meta_pixel
Tapesearch Logo
Log in
This Week in Cardiology

Sep 22 2023 This Week in Cardiology

This Week in Cardiology

Medscape Podcasts

Medicine, Science, Health & Fitness

4.9963 Ratings

🗓️ 22 September 2023

⏱️ 25 minutes

🧾️ Download transcript

Summary

Coronary calcium, cardiac arrest survival, Factor XI drug findings, APCs and a potential new board certification in cardiology are the topics discussed by John Mandrola, MD in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I Coronary Artery Calcium

-   CONFIRM Registry - https://doi.org/10.1016/j.jcmg.2023.03.008

-   CURE -- https://www.nejm.org/doi/full/10.1056/nejmoa010746

II Cardiac Arrest

Cardiac Arrest Centers No Benefit in OHCA Without STEMI

https://www.medscape.com/viewarticle/995885

-   Cycling coverage https://velo.outsideonline.com/road/road-racing/nathan-van-hooydonck-forced-to-end-to-racing-career-due-to-heart-condition/

-   ARREST https://doi.org/10.1016/S0140-6736(23)01351-X

-   SCD in Athletes Bob Harrington and Manesh Patel https://www.medscape.com/viewarticle/995575

III Factor XI

Trial Halted for Bleeding Reduction With Abelacimab vs Rivaroxaban in AF

https://www.medscape.com/viewarticle/996587

-   Press Release - https://anthostherapeutics.com/wp-content/uploads/2023/09/2023-09-18-Anthos-Press-Release-final.pdf

-   Abelacimab, a Factor XI Inhibitor, Prevents VTE With Low Bleeding Risk in Knee Replacement

-   NEJM proof-of-concept https://www.nejm.org/doi/full/10.1056/NEJMoa2105872

-   OCEANIC-AF https://classic.clinicaltrials.gov/ct2/show/NCT05643573

-   Will Factor XI Be the Goldilocks Anticoagulant Target? https://www.medscape.com/viewarticle/979634

IV APC Care

NPs and PAs Handling Increasingly More Primary Care Visits: New Studies https://www.medscape.com/viewarticle/996709

BMJ paper -- https://www.bmj.com/content/382/bmj-2022-073933

V Possible Cardiology Board Certification Changes

-   Heart Societies Ready to Split From ABIM Over MOC Disputes https://www.medscape.com/viewarticle/996747

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Transcript

Click on a timestamp to play from that location

0:00.0

You're listening to this week in cardiology from the heart

0:03.4

org medscape cardiology this podcast is intended for health care

0:07.6

professionals only any views expressed are the presenters own and do not

0:11.2

necessarily reflect the views of WebMD or Medscape.

0:15.1

You can now access the latest in medical news on your Amazon Alexa-enabled device.

0:19.9

Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I highlight the top

0:24.7

medical stories of the day.

0:26.5

To add Medscape Medical Minute to your flash briefing, search for Medscape Medical Minute on Amazon

0:31.3

and click enable or open the Amazon Alexa app go to skills

0:34.7

search for Medscape Medical Minute and click enable then say Alexa what's the

0:40.1

news or Alexa what's my flash briefing I hope you'll join us.

0:44.0

Hi everyone this is John Mandrola from the Heart

0:47.6

org Medscape cardiology and this is this week in

0:50.8

cardiology for September 22nd, 2023.

0:55.2

This week, more on coronary artery calcium scans,

0:58.9

cardiac arrest survival, good news in Factor 11 drug development, advanced practice clinicians, and a movement

1:07.6

towards a new board certification in cardiology. The first topic today is Corner Area Calcium. Jack Interventions has published an

1:17.6

Observational cohort study looking at the rate of astrosclerotic cardiac events in a group of patients referred for coronary CT scans.

1:26.3

Now they retrospectively made two groups, those with established CAD or vascular disease such as a prior am I stroke or PAD peripheral

1:37.6

disease and the second group were those without atherosclerotic events.

1:42.3

Think of it as a secondary and were those without atherosclerotic events.

1:43.0

Think of it as a secondary and primary prevention groups.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.